Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Apogee Therapeutics is a leading U.S. biotechnology company specializing in the development of advanced biologic therapies for immunological and inflammatory diseases. Through innovative protein engineering technologies, the company targets and addresses key drivers of inflammatory processes.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Apogee Therapeutics is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Apogee Therapeutics last reported quarterly earnings on 8/10/2026 (Q2 2026). Earnings per share (EPS) came in at -1.14 USD.
Apogee Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.